Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jaguar Animal Health

1.98
+0.210011.86%
Pre-market: 1.91-0.0700-3.54%06:21 EDT
Volume:288.69K
Turnover:550.96K
Market Cap:4.31M
PE:-0.02
High:2.00
Open:1.81
Low:1.80
Close:1.77
52wk High:35.25
52wk Low:1.57
Shares:2.17M
Float Shares:2.12M
Volume Ratio:3.14
T/O Rate:13.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-130.6878
EPS(LYR):-130.6878
ROE:-319.25%
ROA:-37.42%
PB:0.78
PE(LYR):-0.02

Loading ...

Jaguar Health Inc. to Present at H.C. Wainwright Annual Global Investment Conference

Reuters
·
Sep 05

Jaguar Health Inc. Files Initial Statement of Beneficial Ownership; Lincoln Alternative Strategies LLC Named as Beneficial Owner

Reuters
·
Aug 30

Jaguar Health Inc. Conducted Annual Meeting of Stockholders

Reuters
·
Aug 20

Jaguar Health Inc. Announces New Clinical Study on Crofelemer for Ultrarare Pediatric Disorder MVID Following Promising Initial Results

Reuters
·
Aug 19

Jaguar Health Inc. Announces Date for 2025 Annual Stockholders Meeting

Reuters
·
Aug 18

Jaguar Health Inc. Unveils Presentation on Novel Plant-Based Medicines for Gastrointestinal Disorders

Reuters
·
Aug 14

Jaguar Health Inc - Enters Sixth Atm Amendment With Ladenburg and Lucid - SEC Filing

THOMSON REUTERS
·
Aug 14

Jaguar Health Extends Lucid's Manager Role in Updated ATM Agreement

Reuters
·
Aug 14

Jaguar Health Q2 2025 EPS $(10.25) Misses $(7.13) Estimate, Sales $2.979M Miss $3.265M Estimate

Benzinga
·
Aug 14

Jaguar Health Inc. Reports 35% Increase in Q2 2025 Revenue, Prescription Products Net Revenue Up 36% from Q1 2025

Reuters
·
Aug 14

Jaguar Health Q2 Net Income USD -10.406 Million

THOMSON REUTERS
·
Aug 14

Jaguar Health Q2 Adjusted Ebitda USD -7.877 Million

THOMSON REUTERS
·
Aug 14

Jaguar Health Inc. CEO to Present at Emerging Growth Conference for Corporate Updates

Reuters
·
Aug 12

Jaguar Health Inc expected to post a loss of $7.13 a share - Earnings Preview

Reuters
·
Aug 09

Jaguar Health Inc. Announces Date for 2025 Annual Stockholders Meeting

Reuters
·
Jul 21

Jaguar Health Inc. Advances European Approval Process for Canalevia with EMA Dossier Submission for General Diarrhea Treatment in Dogs

Reuters
·
Jul 10

Jaguar Health Inc. Announces Amendment to Existing Royalty Interest Agreement with Iliad Research, Reducing Outstanding Balance by $4.25 Million

Reuters
·
Jul 01

Jaguar Health Announces Promising Results from Crofelemer Clinical Trials in Intestinal Failure Patients, Plans for Expedited Regulatory Approval

Reuters
·
Jun 30